Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage

Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children

(2015) Paul S. Thornton et al.   JOURNAL OF PEDIATRICS

Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening

(2014) Arianna Maiorana et al.   CLINICAL ENDOCRINOLOGY

Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome

(2014) Pierangelo Veggiotti et al.   Current Treatment Options in Neurology

Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

(2013) Toni S. Pearson et al.   Current Neurology and Neuroscience Reports

Comorbidity and metabolic context are crucial factors determining neurological sequelae of hypoglycaemia

(2012) SVETLANA GATAULLINA et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway

(2011) Sharon S. McDaniel et al.   EPILEPSIA

The Effect of Recurrent Severe Hypoglycemia on Cognitive Performance in Children With Type 1 Diabetes

(2011) Annalisa Blasetti et al.   JOURNAL OF CHILD NEUROLOGY

Protective effects of d-3-hydroxybutyrate and propionate during hypoglycemic coma: Clinical and biochemical insights from infant rats

(2011) Peter W. Schutz et al.   MOLECULAR GENETICS AND METABOLISM

Congenital hyperinsulinism

(2010) Jean-Baptiste Arnoux et al.   EARLY HUMAN DEVELOPMENT

Metabolic Control of Vesicular Glutamate Transport and Release

(2010) Narinobu Juge et al.   NEURON

Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating Mutations

(2009) S. Sayed et al.   DIABETES

Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support In Vitro Synaptic Transmission During Acute Hypoglycemia

(2009) K. A. Page et al.   DIABETES

Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.

(2008) Henrik B T Christesen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions

(2008) María L. Haces et al.   EXPERIMENTAL NEUROLOGY

Diagnostic Difficulties in Glucokinase Hyperinsulinism

(2008) T. Meissner et al.   HORMONE AND METABOLIC RESEARCH